CAS 18592-13-7|6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione
Introduction：Basic information about CAS 18592-13-7|6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione | ||
|---|---|---|---|
| CAS Number | 18592-13-7 | Molecular Weight | 160.558 |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 493.9ºC at 760 mmHg |
| Molecular Formula | C5H5ClN2O2 | Melting Point | 257 °C (dec.)(lit.) |
| MSDS | ChineseUSA | Flash Point | 252.5ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 6-(chloromethyl)-1H-pyrimidine-2,4-dione |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 493.9ºC at 760 mmHg |
| Melting Point | 257 °C (dec.)(lit.) |
| Molecular Formula | C5H5ClN2O2 |
| Molecular Weight | 160.558 |
| Flash Point | 252.5ºC |
| Exact Mass | 160.003952 |
| PSA | 65.72000 |
| LogP | 0.04 |
| Vapour Pressure | 2.23E-10mmHg at 25°C |
| Index of Refraction | 1.511 |
| InChIKey | VCFXBAPEXBTNEA-UHFFFAOYSA-N |
| SMILES | O=c1cc(CCl)[nH]c(=O)[nH]1 |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933599090 |
Customs
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles5
More Articles| Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase. Bioorg. Med. Chem. 10(3) , 525-30, (2002) A series of water soluble N(1)- and C(6)-substituted uracil pyridinium compounds were prepared as potential inhibitors of thymidine phosphorylase (TP). The C(6)-uracil substituted derivatives were the... | |
| Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase. Bioorg. Med. Chem. 12(13) , 3431-41, (2004) A series of novel 6-methylene-bridged uracil derivatives have been prepared as inhibitors of human thymidine phosphorylase (TP). To enhance the in vivo antitumor activity of fluorinated pyrimidine 2'-... | |
| Syntheses of novel heterocycles as anticancer agents. Bioorg. Med. Chem. 13(10) , 3513-8, (2005) Several pteridine analogues 4-13, 23-26 have been synthesized and tested in vitro against three cancer cell lines, MCF7 (breast), NCI-H460 (lung) and SF-268 (CNS). All tested pteridines can serve as n... |
Synonyms
| 6-(chloromethyl)pyrimidine-2,4(1H,3H)-dione |
| 2,4(1H,3H)-Pyrimidinedione, 6-(chloromethyl)- |
| 6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione |
| EINECS 242-431-9 |
| 6-chloromethylpyrimidine-2,4-dione |
| 6-uracilylmethylchloride |
| MFCD00466419 |
| 6-Chloromethyluracil |
| 6-(Chloromethyl)uracil |
